Brødkrumme Forside Dania Therapeutics Dania Therapeutics Dania Therapeutics is a preclinical company developing novel small molecule therapies to treat Acute myeloid leukemia (AML) and other life-threatening cancers. Relateret nyheder om Dania Therapeutics Venture-firkløver bag millioninvestering i ny type behandling inden for særligt aggressiv kræftform Dania Therapeutics Investeringsår 2023 Lokation Denmark Investors Hannibal Innovation, Vernalis, Eir Ventures, UCPH Ventures Kontakt Lars Gredsted Senior Principal lgr@lundbeckfonden.com Mobil +45 2479 2426 Liane Dupont Associate ldu@lundbeckfonden.com Mobil +45 5141 2812